Konstantin M. Korytov

Konstantin M. Korytov

Auto-generated profile, based on publicly available information

Konstantin M. Korytov

Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2020 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
SBS. V. Balakhonov
S. V. Balakhonov
VDValentina Dubrovina
Valentina Dubrovina
MCM. V. Chesnokova
M. V. Chesnokova
VVV. V. Voitkova
V. V. Voitkova
APA. B. Pyatidesyatnikova
A. B. Pyatidesyatnikova
ZMZh. V. Markevich
Zh. V. Markevich
Изучение гуморального иммунного ответа при лёгкой и бессимптомной формах проявления COVID-19

3 May 2021 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
SBS. V. Balakhonov
S. V. Balakhonov
VDValentina Dubrovina
Valentina Dubrovina
APA. B. Pyatidesyatnikova
A. B. Pyatidesyatnikova
DBD. D. Briukhova
D. D. Briukhova
NKN. O. Kiseleva
N. O. Kiseleva
ASA. A. Seledtcov
A. A. Seledtcov
Background. The ongoing COVID-19 pandemic in the world and in Russia remains the main event in 2020. A comprehensive study of the patterns of development and manifestations of the epidemic process of the new coronavirus infection COVID-19 is an urgent line of research. One of the important aspects of the fight against COVID-19 is the study of population immunity to the SARS-CoV-2 virus in order to assess seroprevalence and the formation process of post-infectious humoral immunity to SARS-CoV-2, forecast the development of the epidemiological situation, identify the features of the epidemic process, as well as planning measures for specific and non-specific disease prevention. The aim of the research is to determine the level and structure of population immunity to SARS-CoV-2 among the humans of the Irkutsk region during the COVID-19 epidemic. Materials and methods. As part of the Rospotrebnadzor project to assess population immunity to SARS-CoV-2 in the population of the Russian Federation, research is being conducted among the population of the Irkutsk region in the periods from 06/23/2020 to 07/19/2020 (stage 1), from 09/16/2020 to 09/25/2020 (Stage 2) and from 12/07/2020 to 12/18/2020 (stage 3), taking into account the reacted one recommended by the WHO. The content of antibodies to SARS-CoV-2 was determined by ELISA using a set of tests for human serum or plasma for specific immunoglobulins of class G to the nucleocapsid of the SARS-CoV-2 virus produced by FBUN GNCPMiB Rospotrebnadzor (Obolensk). The results of a research of the humoral immunity of volunteers show that during the period of an epidemic rise in the incidence of COVID-19 in the Irkutsk region, a low level of seroprevalence was formed (stage 1 – 5.8 ± 0.5%, stage 2 – 12,1 ± 0,7%), and in conditions of a long-term maximum increase in the incidence rate ¬– 25,9±1,0% (stage 3). A significant proportion (stage 1 – 81,2±3,2%, stage 2 – 90.9 ±1,9%) of asymptomatic forms of infection characterize the high intensity of the latently developing epidemic process in the first two stages. High levels of IgG in reconvalescents of COVID-19 persisted for an average of 3 to 4.5 months. Conclusion. The results of assessing the population immunity to the SARS-CoV-2 virus in the population of the Irkutsk region indicate that the seroprevalence level at the 3rd stage of the research was 25.9%. After the disease, on average, 41.6% of persons did not detect antibodies. The results obtained should be taken into account when organizing preventive measures, including vaccination, and predicting morbidity.

4 January 2019 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
KKK. M. Korytov
K. M. Korytov
VVV. V. Voitkova
V. V. Voitkova
VDValentina Dubrovina
Valentina Dubrovina
ANA. K. Noskov
A. K. Noskov
AMA. I. Mishchenko
A. I. Mishchenko
LSL. V. Schuchinov
L. V. Schuchinov
Оценка иммунологической эффективности вакцинации населения против чумы в Горно-Алтайском высокогорном природном очаге

27 February 2017 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SBS. V. Balakhonov
S. V. Balakhonov
SVS. A. Vityazeva
S. A. Vityazeva
VDValentina Dubrovina
Valentina Dubrovina
TST. P. Starovoitova
T. P. Starovoitova
GMG. B. Mukhturgin
G. B. Mukhturgin
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov

4 July 2018 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Open access
SBS. A. Bugorkova
S. A. Bugorkova
TST. N. Shchukovskaya
T. N. Shchukovskaya
NMN. I. Mikshis
N. I. Mikshis
SSS. A. Shcherbakova
S. A. Shcherbakova
OKO. M. Kudryavtseva
O. M. Kudryavtseva
VKV. V. Kutyrev
V. V. Kutyrev
The article covers the issues related to the scientific substantiation and methodological support of immunological monitoring of persons vaccinated against plague upon epidemic indications. The problematic issues of the methodology for the assessment of immunological efficiency (efficacy) of plague live vaccine (PLV) are noted. The current tasks and possible prospects for the introduction of immunological monitoring of persons vaccinated against plague upon epidemic indications have been defined. The algorithm of efficacy estimation of plague live vaccine in vaccinated (revaccinated) persons has been tested under real conditions. Analysis of the results of efficacy evaluation of plague live vaccine among vaccinated (revaccinated) people against plague living in the territories of natural foci of this infection has been performed. Demonstrated is the possibility of using immunological monitoring results in creating an objective basis for improving the strategy of specific plague prevention in natural foci of this infection. The priority areas for further optimization of the specific plague prevention in the territories of natural foci of the infection, including those related to the formation of individual regimen revaccination tactics, taking into account the possibilities of creating modern and effective vaccines, are outlined.

14 November 2019 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
KKK. M. Korytov
K. M. Korytov
VVV. V. Voitkova
V. V. Voitkova
VDValentina Dubrovina
Valentina Dubrovina
APA. B. Pyatidesyatnikova
A. B. Pyatidesyatnikova
ANA. K. Noskov
A. K. Noskov
SBS. V. Balakhonov
S. V. Balakhonov
Background. Plague is an especially dangerous natural focal infectious disease belonging to a group of quarantine infections. There are eleven natural plague foci in Russian Federation. In Republic Tyva plague endemic territories include Ovyur, Mongun-Taigin and Tes-Hem areas where Y. pestis strains are intermittently isolated from Citellus undulates. Population living at the territory of the natural foci get immunoprophylaxis against plague at complication of epizootic and epidemic conditions.This paper presents the results of monitoring indicators of the immune status of people vaccinated with the plague vaccine living in the territory of the Tuva natural focus.Materials and methods. The study involved 76 volunteers who had not previously been vaccinated. The study included the determination of production IFN-γ, IL-4, TNF-α by blood cells, titers of specific IgG antibodies to the capsule F1 antigen of the Yersinia pestis, and concentrations of immunoglobulins in serum blood, as well as immunophenotyping of blood lymphocytes.Results. In the course of a comprehensive immunological study, features of the development of cellular and humoral reactions in people living in the territory of the Tuva natural plague focus were established in the first months after vaccination. Changes in the concentration dynamics of the main classes of immunoglobulins were accompanied by an increase in the level of specific IgGs to the F1 within 6 months after immunization. In the same period, a significant increase in the production of cytokines, as well as significant changes in terms of the subpopulation composition of the vaccinated blood.Conclusion. It is necessary to note the importance of studying of the human immune status in 1–3 months after plague vaccination as this period coincides with potentially dangerous season from epidemiological point of view. Nevertheless, much important role for improvement of tactics of the specific prevention measures plays the data received after the revaccination.